Last reviewed · How we verify
NCT04824534: MASSIF
Motion Analysis in Sacroiliac Joint Dysfunction
trial testing Motion analysis in Sacroiliac Joint Dysfunction in 30 participants. Completed in 30 December 2022.
1 September 2022
Quick facts
| Lead sponsor | Zuyderland Medisch Centrum |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 March 2021 |
| Primary completion | 1 September 2022 |
| Estimated completion | 30 December 2022 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Motion analysis
Conditions studied
- Sacroiliac Joint Dysfunction — all drugs for Sacroiliac Joint Dysfunction →
Sponsor
Zuyderland Medisch Centrum — full company profile →
Who can join
Adults 18 to 50, female only, with Sacroiliac Joint Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Rationale: The sacroiliac joint (SIJ) is increasingly being recognized as a potential cause of chronic low back and buttock pain. The SIJ is affected in 14-22% in patients presenting with this pain. Conservative treatment options include oral analgesic use, physical therapy, radiofrequency denervation and intraarticular steroid injections. When non-surgical treatment remains ineffective, surgical intervention is a reasonable option in the form of minimally invasive sacroiliac joint fusion (MISJF). Recent literature suggests that imbalance and sagittal sacropelvic morphology can occur in patients with SIJ dysfunction. Using motion analyses, the investigators want to evaluate full movement patterns in SIJ patients. Potentially, changes in these parameters can be observed before and after MISJF surgery. Objective: To determine spatiotemporal parameters, pelvic obliquity, center of gravity and load capacity in patients suffering from SIJ dysfunction before and after MISJF surgery. Movement parameters will also be determined in healthy individuals to compare with patients suffering from SIJ dysfunction. Methods: This prospective cohort study will include patients enlisted for MISJF surgery because of SIJ dysfunction. Spatiotemporal parameters, pelvic obliquity, center of gravity and load capacity will be examined before and 3 months after surgery in a professional Motion Lab. Movement parameter of healthy individuals will also be evaluated at the Motion Lab. All data will be analyzed using MATLAB software.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04824534
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motion analysis
Trials testing the same drug.
- NCT04154540 — Posturography-Neuropathy · NA · completed
Other recruiting trials for Sacroiliac Joint Dysfunction
Currently open trials in the same condition.
- NCT07310368 — Comparison of the Effectiveness of Mobilization and Myofascial Release Techniques in Patients With Sacroiliac Joint Dysf · NA · recruiting
- NCT07229287 — Kinetic Control Exercises to Reduce Pain and Improve Balance, Walking, and Stamina in Sacroiliac Joint Issues · NA · recruiting
- NCT07037173 — Effect of K-Taping and Yoga Therapy in Postural Correction for Sacroiliac Jointamong Weightlifters · NA · active not recruiting
- NCT06487936 — Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion · recruiting
- NCT06690463 — Comparison of Diagnostic and Therapeutic Efficacy of Periarticular and/or Intraarticular Lidocaine Injections Under Ultr · NA · active not recruiting
Other Zuyderland Medisch Centrum trials
Trials by the same sponsor.
- NCT06896812 — A Pilot Study on App-based Treatment Combining Physical Exercise, Graded Activity, and Pain Journaling for Patients with · NA · not yet recruiting
- NCT05941351 — fixAtion of skiN Flaps After Mastectomy Using ruNning or Interrupted suturEs for Combatting Seroma · NA · not yet recruiting
- NCT06219018 — Effect of Honey For CIN II · Phase 1, PHASE2 · recruiting
- NCT06827834 — Spinal Cord Monitoring in Multiple Sclerosis · recruiting
- NCT06381518 — Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04824534 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zuyderland Medisch Centrum
- Last refreshed: 22 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04824534.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing